Bryan wright

Three behemoths loom over the financial skyline, their market capitalizations breaching the astounding $3 trillion threshold: Nvidia (NASDAQ: NVDA), Microsoft (NASDAQ: MSFT), and Apple (NASDAQ: AAPL). While Apple ascended to the $3 trillion pinnacle back in 2022, Microsoft and Nvidia are fresh inductees to this …

Read more

Comcast’s CMCSA division, Comcast Business, has inked a strategic deal with Starlink to bolster connectivity solutions for its enterprise clientele. This partnership brings Starlink’s cutting-edge satellite capabilities into Comcast Business’ Managed Connectivity offering, chiefly targeting businesses in underprivileged locales where conventional networks prove insufficient. In …

Read more

As the financial markets ebb and flow, three stocks have caught the eye of discerning investors seeking both stability and income potential this June 24th. Provident Financial Services – A Strong Pillar in Banking Provident Financial Services (PFS) stands tall as a community-focused bank with …

Read more

Stellantis Emerges as a Leader in the Electric Vehicle Revolution The automotive industry is currently witnessing a seismic shift towards electric and hybrid vehicles, blazing a trail for the future. In the first quarter of 2024, global EV sales surged by a remarkable 21%, fueled …

Read more

Reviewing Alibaba’s Recent Financial Performance Challenging times have greeted the once robust Alibaba, with its U.S.-listed shares facing a 5% decline this year and a daunting 15% stumble over the past year. The company’s tussle amid cutthroat competition, regulatory reforms, and escalating U.S.-China tensions has …

Read more

The Rocky Road of Rivian’s Stock Investors who leaped at Rivian Automotive‘s (NASDAQ: RIVN) initial public offering were met with a harsh reality as the stock price plummeted almost 60% from its yearly high. This nosedive becomes even more staggering when considering that Rivian shares …

Read more

In the fiercely competitive market of weight loss therapy, giants Eli Lilly and Novo Nordisk stand tall. With their blockbuster weight loss drugs Zepbound (tirzepatide) and Wegovy (tirzepatide), these pharmaceutical powerhouses are set to reign supreme, as predicted by two notable Street analysts. Market Dominance …

Read more

Maintaining stocks for eternity may seem prudent, reminiscent of Warren Buffett’s timeless strategy. I typically refrain from selling unless faced with an irretrievable loss. However, my substantial stake in Apple (NASDAQ: AAPL) beckons a review. The colossal growth of my Apple shares, now exceeding a …

Read more

Investors have witnessed a meteoric rise in the technology sector in recent years, driven by the artificial intelligence (AI) revolution. This era has birthed astonishing rallies that have single-handedly elevated the overall market to new heights. Notably, the “Magnificent Seven” stocks collectively added a jaw-dropping …

Read more

A Soaring Giant: Alphabet’s Journey Alphabet’s stock has taken flight, rising over 40% in the last year to touch new heights. Investors’ hearts were won over by the robust growth in advertising and cloud services, a massive $70 billion buyback scheme, and the inaugural dividend …

Read more